Health AI Startup Medial EarlySign Raises $30 Million

Medial EarlySign, a leader of machine-learning based solutions to improve patient management and non-communicable disease management, today announced completion of a $30 million Series B round of financing. The round was led by the aMoon Fund and included participation from Horizons Ventures, and Nir Kalkstein, a Medial EarlySign co-founder and the founder of high-speed trading firm Final.

Medial EarlySign’s machine-learning based models identify individuals at high risk of developing specific illnesses and optimize care by analyzing dozens of factors related to EHRs, including laboratory tests results, demographics, medication and diagnostic codes. The company is developing a suite of predictive models and algorithmic calculators to help healthcare organizations accurately classify individuals, provide personalized insights to enhance decision-making, and create actionable opportunities for early intervention to delay or prevent progression of illness, improving patient outcomes while reducing overall costs.